Acute chest syndrome in sickle cell disease.


Journal

Nursing
ISSN: 1538-8689
Titre abrégé: Nursing
Pays: United States
ID NLM: 7600137

Informations de publication

Date de publication:
01 Aug 2024
Historique:
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 25 7 2024
Statut: ppublish

Résumé

Sickle cell disease (SCD) is an autosomal recessive disorder altering the shape of red blood cells, causing harmful obstructions in blood vessels, therefore altering normal blood flow. SCD can escalate quickly into acute chest syndrome (ACS), a life-threatening complication that requires immediate care. This article discusses the pathophysiology, assessment, diagnosis, and treatment of ACS, as well as nursing care and patient education.

Identifiants

pubmed: 39051957
doi: 10.1097/NSG.0000000000000004
pii: 00152193-202408000-00011
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-41

Informations de copyright

Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

Références

Cleveland Clinic. Sickle cell disease. https://my.clevelandclinic.org/health/diseases/12100-sickle-cell-disease. Accessed December 4, 2023.
Friend A, Settelmeyer TP, Girzadas D. Acute chest syndrome. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2023. www.ncbi.nlm.nih.gov/books/NBK441872/.
Cleveland Clinic. Sickle cell anemia (sickle cell disease). https://my.clevelandclinic.org/health/diseases/4579-sickle-cell-anemia.
Cleveland Clinic. Acute chest syndrome. https://my.clevelandclinic.org/health/diseases/23290-acute-chest-syndrome. Accessed February 26, 2023.
Tanabe P, Spratling R, Smith D, Grissom P, Hulihan M. CE: understanding the complications of sickle cell disease. Am J Nurs. 2019;119(6):26–35. doi:10.1097/01.NAJ.0000559779.40570.2c.
Riley K, Evans MM, Kowalchik K, Adams L, Lucey M. Sickle cell anemia: best practices for patient-centered care. Nursing Made Incredibly Easy! 2020;18(6):26–33. doi:10.1097/01.NME.0000717640.57159.b5.
Koehl JL, Koyfman A, Hayes BD, Long B. High risk and low prevalence diseases: acute chest syndrome in sickle cell disease. Am J Emerg Med. 2022;58:235–244. doi:10.1016/j.ajem.2022.06.018.
Mangla A, Ehsan M, Agarwal N, Maruvada S. Sickle cell anemia. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2023. www.ncbi.nlm.nih.gov/books/NBK482164/.
Field JJ, Willen S. Acute chest syndrome (ACS) in sickle cell disease (adults and children). UpToDate. www.uptodate.com/contents/acute-chest-syndrome-acs-in-sickle-cell-disease-adults-and-children#H33318346. Accessed December 4, 2023.
National Heart Lung, and Blood Institute. Sickle cell disease: symptoms. www.nhlbi.nih.gov/health/sickle-cell-disease/symptoms. Accessed December 4, 2023.
Centers for Disease Control and Prevention. Stroke signs and symptoms. www.cdc.gov/stroke/signs_symptoms.htm. Accessed September 11, 2023.
Inker L, Perrone R. Assessment of kidney function. www.uptodate.com/contents/assessment-of-kidney-function#H963085581. Accessed September 11, 2023.
Cleveland Clinic. Liver failure. https://my.clevelandclinic.org/health/diseases/17819-liver-failure. Accessed September 11, 2023.
Stussi G, Buser A, Holbro A. Red blood cells: exchange, transfuse, or deplete. Transfus Med Hemother. 2019;46(6):407–416. doi:10.1159/000504144.
Bhasin N, Sarode R. Acute chest syndrome in sickle cell disease. Transfus Med Rev. 2023;37(3). doi:10.1016/j.tmrv.2023.150755.
Centers for Disease Control and Prevention. Infection control: standard precautions for all patient care. www.cdc.gov/infectioncontrol/basics/standard-precautions.html.
Bell V, Varzakas T, Psaltopoulou T, Fernandes T. Sickle cell disease update: new treatments and challenging nutritional interventions. Nutrients. 2024;16(2):258. doi:10.3390/nu16020258.
Ciccone CD. Hydroxyurea. In: Davis's Drug Guide for Rehabilitation Professionals. F.A. Davis Company; 2016. https://fadavispt.mhmedical.com/content.aspx?bookid=1873&sectionid=139013772. Accessed February 13, 2024.
Food and Drug Agency. FDA approves first gene therapies to treat patients with sickle cell disease. 2023. www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease.

Auteurs

Annamarie M Talarico (AM)

Annamarie Talarico is an RN at University Hospitals Cleveland Medical Center Seidman Cancer Center in Cleveland, Ohio. The author acknowledges the support of graduate professors Marcy Caplin, PhD, RN, CNE and Tina Saunders, PhD, RN, CNE, GCNS-BC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH